Clinical Trials Browser

Phase 1 × Hematologic Neoplasms × talquetamab × Clear all

NCT03399799 2026-03-12

MonumenTAL-1

Phase 1 Active not recruiting

279 enrolled 1 FDA

Other hematologic neoplasm

Hematologic Neoplasms